Skip to main content

Table 3 Longitudinal Renal Function

From: Treatment of post-transplant recurrent FSGS in children using plasmapheresis and augmentation of immunosuppression

Renal function

n = 17

At 7 days, median (IQR)

 Serum creatinine [mg/dL]

1.63 (0.58–2.89)

 Schwartz eGFR [mL/min/1.73 m2]

50.6 (27.5–84.6)

At 15 days, median (IQR)

 Serum creatinine [mg/dL]

1.1 (0.7–2.8)

 Schwartz eGFR [mL/min/1.73 m2]

61.2 (27.1–78.8)

At 30 days, median (IQR)

 Serum creatinine [mg/dL]

1.0 (0.8–2.9)

 Schwartz eGFR [mL/min/1.73 m2]

60.3 (28.6–67.9)

At discharge, median (IQR)

 Serum creatinine [mg/dL]

1.0 (0.8–1.7)

 Schwartz eGFR [mL/min/1.73 m2]

61.0 (42.2–74.0)

At year, median (IQR)

 Serum creatinine [mg/dL],

1.04 (0.78–2.3)

 Schwartz eGFR [mL/min/1.73 m2]

57.7 (30.7–77.1)

At last follow-up, median (IQR)

 Time of follow-up

4.0 (2.2–7.8)

 Serum creatinine [mg/dL]

1.63 (1.2–2.3)

 Schwartz eGFR [mL/min/1.73 m2]

42.8 (33.1–55.8)

Protein/Creatinine ratio, median (IQR)

 At diagnosis of recurrence

6.2 (3.0–10.1)

 At hospital discharge

0.35 (0.25–0.66)

 3 months post-transplant

0.3 (0.25–0.4)

 12 months post-transplant

0.095 (0.08–0.10)

 72 months post-transplant

0.1 (0.095–0.16)